⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Mark FadelMD, JD

Otolaryngology · Houston, TX 77030

NPI: 1346700234

Share:

35

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers95th percentile opioid prescribing

Risk indicators are statistical patterns, not allegations. Learn more

54

Total Claims

$451

Drug Cost

39

Beneficiaries

$12

Cost/Patient

Risk Score Breakdown 35/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Opioid rate (national percentile)+10

Score components are additive. Read full methodology

Peer Comparison vs. 8,957 Otolaryngology providers

+938%

Opioid rate vs peers

55.6% vs 5.3% avg

-91%

Cost per patient vs peers

$12 vs $132 avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 938% above the average for Otolaryngology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

55.6%

Opioid Rate

30

Opioid Claims

$102

Opioid Cost

Long-Acting Rate

This provider's opioid prescribing rate of 55.6% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

100% generic

Brand: 0 claims · $0

Generic: 53 claims · $430

Patient Profile

69

Avg Age

44%

Female

1.50

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About